if its 0.7 - 1%, SGLT2 inhibitors could not be the 3rd compitator drug next to Met
However, certain individuals may not be suited for semaglutide, including those with a personal or familial history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2
Does everyone on GLP-1 medications experience hair loss
Adequate water intake, electrolyte monitoring, and regular provider check-ins during titration help mitigate this risk
Although class effects were observed, variations in molecular structure, receptor affinity, and pharmacokinetics may contribute to differential outcomes among GLP-1 RAs
LB broth (100 mL) supplemented with D-glucose (0.2%) was inoculated with an overnight pre-culture (10 3 cfu/mL) and, then, incubated at 24 C in baffled flasks (500 mL) whilst rotary shaking (150 rpm)